ADHD is treated with two main classes of medication: stimulants and non-stimulants. Stimulants are the first-line treatment for most people and work for roughly 70% to 80% of those who try them. They fall into two families, methylphenidate and amphetamine, each available in dozens of brand-name formulations. Non-stimulants are typically used when stimulants cause intolerable side effects or aren’t a good fit due to other health conditions.
How ADHD Medications Work in the Brain
ADHD involves underactivity in the prefrontal cortex, the part of your brain responsible for focus, impulse control, and planning. Stimulant medications increase the availability of two chemical messengers, dopamine and norepinephrine, in that region. In practical terms, dopamine helps filter out distracting “noise” while norepinephrine strengthens the signals that matter. The result is sharper attention, less impulsivity, and better follow-through on tasks.
Non-stimulants target some of the same brain chemistry but through different routes. Atomoxetine, for instance, primarily boosts norepinephrine. Others, like guanfacine and clonidine, calm overactive stress-response circuits that contribute to hyperactivity and emotional reactivity. Because they work differently, non-stimulants tend to have a slower onset and a different side-effect profile than stimulants.
Stimulants: Methylphenidate vs. Amphetamine
Every FDA-approved stimulant for ADHD belongs to one of two families. Methylphenidate is the active ingredient in brands like Ritalin, Concerta, Focalin, and the Daytrana patch. Amphetamine-based options include Adderall, Vyvanse, and Dyanavel. Both families are effective, but a large systematic review of over 10,000 adults found that amphetamines produced a greater improvement in symptoms than methylphenidate. Tolerability, measured by how many people dropped out of studies due to side effects, was similar between the two.
That doesn’t mean amphetamines are automatically the better choice. Individual brain chemistry varies, and many people respond well to methylphenidate but poorly to amphetamine, or vice versa. Prescribers often start with one and switch to the other if the response isn’t adequate.
Short-Acting vs. Long-Acting Formulations
Within each stimulant family, you’ll find short-acting and long-acting versions. Short-acting tablets kick in within 30 to 45 minutes and wear off in about 3 to 6 hours, which means they may need to be taken two or three times a day. Long-acting formulations use extended-release technology to stretch coverage across the day with a single dose.
Duration varies by product. Concerta (methylphenidate) lasts 8 to 12 hours. Ritalin LA covers about 8 to 10 hours. Vyvanse (lisdexamfetamine), a prodrug that your body converts into its active form after you swallow it, lasts 10 to 12 hours. Azstarys, a newer methylphenidate combination, can last up to 13 hours. There’s even a formulation called Jornay PM designed to be taken at bedtime: it doesn’t activate until 10 to 12 hours later, so it’s working by the time you wake up.
The choice between short and long-acting often comes down to lifestyle. Long-acting versions are popular because they eliminate the need for a midday dose, which is especially helpful for children at school or adults at work. Short-acting options offer more flexibility if you only want coverage for specific parts of the day.
FDA-Approved Non-Stimulant Options
The FDA has approved four non-stimulant medications for ADHD:
- Atomoxetine (Strattera) is the most commonly prescribed non-stimulant. It increases norepinephrine activity and typically takes 2 to 4 weeks to reach its full effect, unlike stimulants that work the same day.
- Viloxazine (Qelbree) is a newer option that also affects norepinephrine along with serotonin. It was approved for children in 2021 and later for adults.
- Guanfacine (Intuniv) works by calming certain brain circuits involved in attention and emotional regulation. It’s often used alongside a stimulant rather than as a standalone treatment.
- Clonidine (Kapvay) is similar to guanfacine and is particularly helpful for hyperactivity, impulsivity, and sleep difficulties tied to ADHD.
Non-stimulants are not controlled substances, which means they carry no risk of misuse. This makes them a common choice for people with a history of substance use disorders or for those who experience significant anxiety on stimulants.
ADHD Medication and Coexisting Conditions
Many people with ADHD also live with anxiety, depression, or other conditions, which complicates medication decisions. One concern is that stimulants might worsen anxiety, but the evidence is nuanced. A meta-analysis of children and adolescents found that those taking stimulant medications actually had a 20% lower risk of developing depression compared to those not on stimulants. Atomoxetine and certain antidepressants are also used in cases where ADHD overlaps with mood or anxiety disorders.
When other conditions are present, prescribers typically adjust doses more slowly and monitor more frequently. The goal is to find the point where ADHD symptoms improve without aggravating anything else.
Common Side Effects
Decreased appetite is by far the most common side effect of stimulants, affecting roughly 80% of people who take them. This often leads to some weight loss, especially in the first few months. Taking medication after meals or adding protein-rich snacks can help offset this.
Sleep disruption is the other big one. Stimulants can make it harder to fall asleep and reduce overall sleep quality, which is one reason timing and formulation choice matter. A long-acting pill taken too late in the day will keep you up. Slight increases in heart rate and blood pressure can also occur, though these changes are usually minor. People with a history of heart problems should make sure their prescriber knows before starting treatment.
Non-stimulants carry their own side-effect profiles. Atomoxetine can cause nausea and fatigue, particularly when first starting. Guanfacine and clonidine may cause drowsiness and low blood pressure, which is why they’re sometimes given at bedtime.
What Starting Medication Looks Like
Getting on ADHD medication isn’t a one-appointment process. Treatment begins with a low dose that gets gradually increased, a process called titration. During this phase, you (or your child’s teachers and caregivers) will track symptoms and side effects, often using standardized rating scales. The dose goes up in small increments, typically at weekly or biweekly intervals, until symptoms improve without causing bothersome side effects.
The right dose is not determined by body size, age, or how severe your symptoms seem. It’s determined by your individual response. Two people of the same weight with similar symptoms may end up on very different doses. Once the dose is optimized, check-ins shift to every few months to make sure things are still working well and to adjust if circumstances change.
For many people, finding the right medication and dose takes some trial and error. Switching between methylphenidate and amphetamine, trying different release durations, or adding a non-stimulant are all common adjustments that don’t mean treatment is failing. They mean it’s being fine-tuned.